NcRNAs-mediated P2RX1 expression correlates with clinical outcomes and immune infiltration in patients with breast invasive carcinoma

The development of novel treatments for breast invasive carcinoma (BC) has been stagnant. P2RX1, a member of the purinergic receptor family, has been found to have a prognostic impact in several tumors. Therefore, we analyzed the expression pattern of P2RX1 in pan-cancers including BC and its impact...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yiyue, Zou, Bing, Fan, Bingjie, Li, Butuo, Yu, Jinming, Wang, Linlin, Zhang, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186779/
https://www.ncbi.nlm.nih.gov/pubmed/35585027
http://dx.doi.org/10.18632/aging.204087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186779/
https://www.ncbi.nlm.nih.gov/pubmed/35585027
http://dx.doi.org/10.18632/aging.204087

Ejemplares similares